247 related articles for article (PubMed ID: 1816508)
1. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus.
Moncada C; Arvin B; Le Peillet E; Meldrum BS
Neurosci Lett; 1991 Dec; 133(2):287-90. PubMed ID: 1816508
[TBL] [Abstract][Full Text] [Related]
2. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally.
Lees GJ; Leong W
Brain Res; 1993 Nov; 628(1-2):1-7. PubMed ID: 7508807
[TBL] [Abstract][Full Text] [Related]
4. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
Parsons CG; Gruner R; Rozental J
Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
[TBL] [Abstract][Full Text] [Related]
5. Effect of NO synthase inhibition on NMDA- and ischaemia-induced hippocampal lesions.
Moncada C; Lekieffre D; Arvin B; Meldrum B
Neuroreport; 1992 Jun; 3(6):530-2. PubMed ID: 1382661
[TBL] [Abstract][Full Text] [Related]
6. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
[TBL] [Abstract][Full Text] [Related]
7. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
Kristensen BW; Noraberg J; Zimmer J
Brain Res; 2001 Oct; 917(1):21-44. PubMed ID: 11602227
[TBL] [Abstract][Full Text] [Related]
8. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
Liljequist S; Cebers G; Kalda A
Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.
Foster AC; Gill R; Woodruff GN
J Neurosci; 1988 Dec; 8(12):4745-54. PubMed ID: 2904493
[TBL] [Abstract][Full Text] [Related]
10. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo.
Massieu L; Tapia R
Neuroscience; 1994 Apr; 59(4):931-8. PubMed ID: 7520137
[TBL] [Abstract][Full Text] [Related]
11. Domoic acid neurotoxicity in hippocampal slice cultures.
Jakobsen B; Tasker A; Zimmer J
Amino Acids; 2002; 23(1-3):37-44. PubMed ID: 12373516
[TBL] [Abstract][Full Text] [Related]
12. NBQX prevents contralateral but not ipsilateral seizure-induced cytotoxicity of kainate but not AMPA-reversal at high doses of NBQX.
Lees GJ; Leong W
Neuroreport; 1994 Oct; 5(16):2153-6. PubMed ID: 7532455
[TBL] [Abstract][Full Text] [Related]
13. Kainate toxicity in energy-compromised rat hippocampal slices: differences between oxygen and glucose deprivation.
Schurr A; Rigor BM
Brain Res; 1993 Jun; 614(1-2):10-4. PubMed ID: 7688644
[TBL] [Abstract][Full Text] [Related]
14. A paradox after systemic kainate injection in rats: lesser damage of hippocampal CA1 neurons after higher doses.
Balchen T; Berg M; Diemer NH
Neurosci Lett; 1993 Dec; 163(2):151-4. PubMed ID: 8309622
[TBL] [Abstract][Full Text] [Related]
15. In vivo, the direct and seizure-induced neuronal cytotoxicity of kainate and AMPA is modified by the non-competitive antagonist, GYKI 52466.
Lees GJ; Leong W
Brain Res; 2001 Jan; 890(1):66-77. PubMed ID: 11164769
[TBL] [Abstract][Full Text] [Related]
16. Mobilization of dantrolene-sensitive intracellular calcium pools is involved in the cytotoxicity induced by quisqualate and N-methyl-D-aspartate but not by 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionate and kainate in cultured cerebral cortical neurons.
Frandsen A; Schousboe A
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2590-4. PubMed ID: 1372982
[TBL] [Abstract][Full Text] [Related]
17. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
Ruiz A; Durand J
Brain Res Bull; 2000 May; 52(2):99-107. PubMed ID: 10808079
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cyclothiazide-enhanced kainate excitotoxicity in rat hippocampal cultures.
Ohno K; Okada M; Tsutsumi R; Matsumoto N; Yamaguchi T
Neurochem Int; 1998 Mar; 32(3):265-71. PubMed ID: 9587920
[TBL] [Abstract][Full Text] [Related]
19. The non-NMDA glutamate antagonist NBQX blocks the local hippocampal toxicity of kainic acid, but not the diffuse extrahippocampal damage.
Lees GJ; Leong W
Neurosci Lett; 1992 Aug; 143(1-2):39-42. PubMed ID: 1331904
[TBL] [Abstract][Full Text] [Related]
20. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.
Sheardown MJ; Nielsen EO; Hansen AJ; Jacobsen P; Honoré T
Science; 1990 Feb; 247(4942):571-4. PubMed ID: 2154034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]